Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Henry Schein Stock Underperforming the S&P 500?

With a market cap of $8.5 billion, Henry Schein, Inc. (HSIC) is a global healthcare distribution and solutions company headquartered in Melville, New York. It is one of the world’s largest providers of medical, dental, and veterinary supplies, equipment, and practice management solutions, serving healthcare professionals across more than 30 countries.

Companies valued between $2 billion and $10 billion are generally classified as “mid-cap” stocks, and Henry Schein fits this criterion perfectly. Henry Schein’s core edge is its integrated “one-stop-shop” ecosystem, where a broad distribution network is tightly coupled with software, financial services, and consulting, creating deep customer dependence, recurring revenue...

Fundamentals

See More
  • Market Capitalization, $K 21,489,788
  • Shares Outstanding, K 109,866
  • Annual Sales, $ 11,035 M
  • Annual Income, $ 992,000 K
  • EBIT $ 1,710 M
  • EBITDA $ 2,280 M
  • 60-Month Beta 0.65
  • Price/Sales 1.94
  • Price/Cash Flow 12.87
  • Price/Book 3.01

Options Overview Details

View History
  • Implied Volatility 28.44% (+0.47%)
  • Historical Volatility 26.73%
  • IV Percentile 92%
  • IV Rank 50.85%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 24) 13.77 (7.01%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 592
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 7,743
  • Open Int (30-Day) 14,049
  • Expected Range 182.66 to 210.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.35
  • Number of Estimates 10
  • High Estimate 2.51
  • Low Estimate 2.04
  • Prior Year 2.21
  • Growth Rate Est. (year over year) +6.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
192.79 +1.98%
on 03/20/26
213.50 -7.91%
on 02/27/26
-12.93 (-6.17%)
since 02/24/26
3-Month
171.18 +14.86%
on 01/05/26
213.50 -7.91%
on 02/27/26
+20.69 (+11.76%)
since 12/24/25
52-Week
157.20 +25.07%
on 04/09/25
213.50 -7.91%
on 02/27/26
+29.28 (+17.50%)
since 03/24/25

Most Recent Stories

More News
Is Henry Schein Stock Underperforming the S&P 500?

Henry Schein has trailed behind the S&P 500 Index, yet Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 144.39 (-0.26%)
HSIC : 73.98 (-0.64%)
DGX : 196.17 (+0.29%)
$SPX : 6,576.78 (-0.06%)
Is Labcorp Holdings Stock Underperforming the S&P 500?

Labcorp Holdings has rallied behind the S&P 500 Index over the past year, yet analysts remain highly optimistic about the stock’s growth potential.

DGX : 196.17 (+0.29%)
$SPX : 6,576.78 (-0.06%)
LH : 266.92 (+0.95%)
Digi Power X to Announce 2025 Year End Financial Results on March 31st

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 196.17 (+0.29%)
DGX.NE : 3.2700 (+2.51%)
DGX.VN : 3.790 (+5.28%)
DGXX : 2.31 (-3.35%)
3 Mid-Cap Stocks with Warning Signs

3 Mid-Cap Stocks with Warning Signs

CINF : 159.87 (+0.39%)
DGX : 196.17 (+0.29%)
CHTR : 218.50 (+0.87%)
3 Reasons to Avoid DGX and 1 Stock to Buy Instead

3 Reasons to Avoid DGX and 1 Stock to Buy Instead

DGX : 196.17 (+0.29%)
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026

SECAUCUS, N.J. , March 19, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report first quarter 2026 financial...

DGX : 196.17 (+0.29%)
How Is Quest Diagnostics’ Stock Performance Compared to Other Healthcare Stocks?

Quest Diagnostics has outpaced its healthcare peers over the past year, and analysts are maintaining a moderately positive outlook on its future performance.

XLV : 144.39 (-0.26%)
DGX : 196.17 (+0.29%)
EXAS : 104.91 (+0.95%)
1 Healthcare Stock with Exciting Potential and 2 We Avoid

1 Healthcare Stock with Exciting Potential and 2 We Avoid

AMN : 18.56 (+0.92%)
DGX : 196.17 (+0.29%)
PODD : 224.77 (-1.02%)
Digi Power X Provides Clarification on US Data Centers Transaction

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 196.17 (+0.29%)
DGXX : 2.31 (-3.35%)
Hans Vestberg Co-Founds Next Phase of US Data Centers Inc. with Digi Power X to Deploy Modular AI Infrastructure at Scale

This news release constitutes a "designated news release" for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated...

DGX : 196.17 (+0.29%)
DGX.NE : 3.2700 (+2.51%)
DGX.VN : 3.790 (+5.28%)
DGXX : 2.31 (-3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 208.28
2nd Resistance Point 205.59
1st Resistance Point 200.60
Last Price 196.17
1st Support Level 192.92
2nd Support Level 190.23
3rd Support Level 185.24

See More

52-Week High 213.50
Last Price 196.17
Fibonacci 61.8% 191.99
Fibonacci 50% 185.35
Fibonacci 38.2% 178.71
52-Week Low 157.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.